Handling Baselines in Repeated Measures Analyses with Missing Data at Random

被引:9
作者
Dinh, Phillip [1 ]
Yang, Peiling [1 ]
机构
[1] US FDA, Div Biometr 1, Off Biostat Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
关键词
Baseline; Longitudinal data; Missing at random; MMRM; CLINICAL-TRIALS; COVARIANCE; LIKELIHOOD; INFERENCE; MODELS;
D O I
10.1080/10543406.2011.550113
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In longitudinal clinical studies, after randomization at baseline, subjects are followed for a period of time for development of symptoms. A mixed model for repeated measures (MMRM) can be used to analyze data from such studies. Fitzmaurice et al. (2004) outlined five approaches for handling baseline responses in an MMRM analysis. They are: (1) Retain the baselines as part of the outcome vector and make no assumptions about group differences in the mean response at baseline. (2) Retain the baselines as part of the outcome vector and assume the group means are equal at baseline. (3) Subtract the baselines from all of the remaining post-baseline responses, and analyze the differences from baseline. (4) Use the baselines as a covariate in the analysis of the post-baseline responses, assuming homogeneous regression slopes. (5) Use the baselines as a covariate in the analysis of the post-baseline responses, allowing different regression slopes. In this paper, we evaluate these five approaches in the presence of data missing at random. We evaluate the approaches based on the bias of the estimate and the coverage accuracy of the confidence interval. The results suggest that strategies 2 and 5 are recommended.
引用
收藏
页码:326 / 341
页数:16
相关论文
共 25 条
[1]  
[Anonymous], 2004, Applied Longitudinal Analysis
[2]   Direct likelihood analysis versus simple forms of imputation for missing data in randomized clinical trials [J].
Beunckens, C ;
Molenberghs, G ;
Kenward, MG .
CLINICAL TRIALS, 2005, 2 (05) :379-386
[3]   APPROXIMATE INFERENCE IN GENERALIZED LINEAR MIXED MODELS [J].
BRESLOW, NE ;
CLAYTON, DG .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1993, 88 (421) :9-25
[4]   ANALYSIS OF COVARIANCE IN PARALLEL-GROUP CLINICAL-TRIALS WITH PRETREATMENT BASELINES [J].
CRAGER, MR .
BIOMETRICS, 1987, 43 (04) :895-901
[5]   THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) FOR SCHIZOPHRENIA [J].
KAY, SR ;
FISZBEIN, A ;
OPLER, LA .
SCHIZOPHRENIA BULLETIN, 1987, 13 (02) :261-276
[6]   Small sample inference for fixed effects from restricted maximum likelihood [J].
Kenward, MG ;
Roger, JH .
BIOMETRICS, 1997, 53 (03) :983-997
[7]  
LAID NM, 1982, BIOMETRICS, V38, P963
[8]   Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches [J].
Lane, Peter .
PHARMACEUTICAL STATISTICS, 2008, 7 (02) :93-106
[9]  
LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13
[10]  
Liang KY., 2000, Sankhya: The Indian Journal of Statistics, Series B, V62, P134, DOI DOI 10.2307/25053123